As drugmakers are turning more often to technology to make their plants and R&D more productive, they are looking for help with information technology services. Novo Nordisk ($NVO) sees an opportunity in that. The Denmark-based insulin specialist thinks its IT services operation, NNIT, is pretty special, and is looking at spinning it off into a separate business. As FiercePharma reports, Novo has hired Morgan Stanley and Danske Bank to advise it on a potential deal. Story